AWH Aspira Women's Health Inc
Price (delayed)
$0.106
Market cap
$3.16M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.93
Enterprise value
$4.76M
Aspira Women's Health Inc. operates as a biotech company. The Company develops and discovers testing and treatments for gynecologic issues. Aspira Women's Health serves customers in the State of Texas.
Highlights
The EPS has grown by 49% YoY and by 21% from the previous quarter
The net income has grown by 22% year-on-year and by 11% since the previous quarter
The debt has surged by 58% since the previous quarter and by 18% year-on-year
The company's quick ratio fell by 40% YoY and by 19% QoQ
Key stats
What are the main financial stats of AWH
Market
Valuations
Earnings
Shares outstanding
29.76M
Market cap
$3.16M
Enterprise value
$4.76M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.52
Revenue
$9.18M
Gross profit
$5.48M
Operating income
-$16.28M
Net income
-$13.09M
EBIT
-$13.06M
EBITDA
-$12.97M
Free cash flow
-$12.15M
Per share
Balance sheet
Liquidity
EPS
-$0.93
EPS diluted
-$0.93
Free cash flow per share
-$0.86
Book value per share
-$0.15
Revenue per share
$0.65
TBVPS
$0.39
Total assets
$5.49M
Total liabilities
$8.05M
Debt
$3.38M
Equity
-$2.56M
Working capital
-$1.29M
Debt to equity
-1.32
Current ratio
0.76
Quick ratio
0.5
Net debt/EBITDA
-0.12
Margins
Efficiency
Dividend
EBITDA margin
-141.2%
Gross margin
59.7%
Net margin
-142.6%
Operating margin
-177.3%
Return on assets
-245%
Return on equity
N/A
Return on invested capital
-3,041%
Return on capital employed
-56,787%
Return on sales
-142.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AWH stock price
How has the Aspira Women's Health stock price performed over time
Intraday
10.42%
1 week
1.92%
1 month
-35.99%
1 year
-96.13%
YTD
-84.96%
QTD
12.89%
Financial performance
How have Aspira Women's Health's revenue and profit performed over time
Revenue
$9.18M
Gross profit
$5.48M
Operating income
-$16.28M
Net income
-$13.09M
Gross margin
59.7%
Net margin
-142.6%
The net margin has increased by 22% year-on-year and by 14% since the previous quarter
The net income has grown by 22% year-on-year and by 11% since the previous quarter
The operating income has grown by 14% year-on-year and by 4.1% since the previous quarter
Aspira Women's Health's operating margin has increased by 14% YoY and by 6% from the previous quarter
Growth
What is Aspira Women's Health's growth rate over time
Valuation
What is Aspira Women's Health stock price valuation
P/E
N/A
P/B
N/A
P/S
0.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.52
The EPS has grown by 49% YoY and by 21% from the previous quarter
The company's equity fell by 8% YoY
AWH's price to sales (P/S) is 100% less than its 5-year quarterly average of 36.9 and 93% less than its last 4 quarters average of 2.2
Aspira Women's Health's revenue has increased by 2.4% from the previous quarter
Efficiency
How efficient is Aspira Women's Health business performance
Aspira Women's Health's ROIC has decreased by 40% YoY but it has increased by 37% from the previous quarter
The ROA has contracted by 25% YoY but it has grown by 8% from the previous quarter
The ROS has grown by 22% YoY and by 14% from the previous quarter
Dividends
What is AWH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AWH.
Financial health
How did Aspira Women's Health financials performed over time
Aspira Women's Health's total assets is 32% less than its total liabilities
The company's quick ratio fell by 40% YoY and by 19% QoQ
The company's current ratio fell by 26% YoY
The debt has surged by 58% since the previous quarter and by 18% year-on-year
Aspira Women's Health's debt to equity has plunged by 55% from the previous quarter and by 9% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.